Cell-mediated immunity in multiple sclerosis. 1977

L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie

The blastogenic response of MS lymphocytes to a group of paramyxovirus antigens and to phytohemagglutinin was investigated. Comparative studies were performed in a selected group of patients before and after transfer factor therapy. There was no blastogenic response of lymphocytes to the paramyxovirus antigens tested in MS patients and normal controls, as measured by the incorporation of 14C thymidine. The stimulation index was below 2.5 even after transfer factor therapy. Lymphocyte transformation induced by PHA appeared significantly depressed in the MS patient group before transfer factor therapy when compared with the normal control group. The presence of serum factors that may depress PHA-induced lymphocyte transformation were looked for and not found. Following transfer factor therapy, an increase of the PHA response was observed in the MS group, such that a statistically significant difference in response compared with the normal control group was no longer present.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D014165 Transfer Factor Factor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients. Dialyzable Leukocyte Extract,Extract, Dialyzable Leukocyte,Factor, Transfer,Leukocyte Extract, Dialyzable

Related Publications

L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie
January 1983, Progress in brain research,
L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie
January 1977, Acta neurologica Scandinavica. Supplementum,
L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie
January 1990, Autoimmunity,
L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie
January 1975, Transactions of the American Neurological Association,
L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie
December 1981, Acta neurologica Scandinavica,
L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie
February 1981, Acta neurologica Scandinavica,
L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie
June 1981, Acta neurologica Scandinavica,
L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie
March 1987, Acta neurologica Scandinavica,
L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie
February 1978, Neurology,
L R Espinoza, and G Ebers, and W Mountcastle, and J B Zabriskie
December 1989, Israel journal of medical sciences,
Copied contents to your clipboard!